Yüklüyor......
How I monitor residual disease in chronic myeloid leukemia
Molecular monitoring in chronic myeloid leukemia (CML) is a powerful tool to document treatment responses and predict relapse. Nonetheless, the proliferation of clinical trials and “guidelines” using the molecular endpoints of CML has outpaced practice norms, commercial laboratory application, and r...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Hematology
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3654782/ https://ncbi.nlm.nih.gov/pubmed/19661271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-02-163485 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|